Quote
—
—
No scored catalysts in the window yet.
Market cap
—
P/E
—
EPS
—
Beta
—
52W range
—
Day range
—
Open
—
Prev close
—
Volume
—
Avg volume
—
Dividend
—
IPO
—
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxt-engages-business-development-and-licensing-advisors-for-commer-1177137 · 6/15/2026+0.60
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxt-secures-unitary-european-patent-for-sublingual-cladribine-odf-1155490 · 4/7/2026+0.90
https://www.reuters.com/business/energy/nextdecade-cfo-brent-wahl-resigns-2025-10-08/ · 10/8/2025-0.20
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxt-reports-sublingual-cladribine-multiple-sclerosis-drug-mileston-1079171 · 9/29/2025+0.80
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxt-solutions-announces-closing-of-shares-for-debt-settlement-1076258 · 9/20/2025
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/terry-lynch-continues-as-capital-markets-advisor-and-bionxt-retains-i-1076225 · 9/19/2025+0.20
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxt-announces-shares-for-debt-settlement-1072759 · 9/12/2025-0.20
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/promotional-activity-engagements-1064541 · 8/23/2025+0.20
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/bionxt-solutions-announces-revocation-of-management-cease-trade-order-1044030 · 6/27/2025+0.30
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
